Andrew Talal, MD, MPH is a physician-scientist with more than 20 years' experience in treating hepatitis C virus (HCV), especially among substance users. He is currently Professor of Medicine at SUNY, University at Buffalo where the results of a stepped wedge randomized controlled trial of facilitated telemedicine for HCV treatment integrated into opioid treatment programs resulted in a 3-fold improvement in HCV cure compared to offsite referral. Dr.

Dr. Pruthvi Patel, MD, MPH, is a hepatologist and Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Her work focuses on expanding access to high-quality liver care through telehepatology and innovative care delivery models.

Maria Buti earned her medical degree at the University of Barcelona and her PhD in Internal Medicine at the University "Autónoma" de Barcelona, Spain. She is currently Professor of Medicine and Consultant of Hepatology at the Hospital General Universitari Valle Hebron, Barcelona. Dr Butí has worked in viral hepatitis for the last 25 years, particularly in diagnosis and therapy of hepatitis B and C.

A physician-scientist and an Assistant Professor of Medicine within the Division of Gastroenterology, Hepatology and Nutrition, and Stravitz-Sanyal Institute for Liver Disease and Metabolic Health (SSI), Virginia Commonwealth University.

Dr. Jeff Teckman is the Drs. James and Patricia Monteleone Endowed Chair, Vice Chair of the Department of Pediatrics, Professor of Pediatrics and Biochemistry at the Saint Louis University School of Medicine and Cardinal Glennon Children's Hospital. He has been involved in research on liver disease for more than 30 years in both basic science and clinical studies. His studies have ranged from viral hepatitis to liver failure in short bowel syndrome, to genetic disease. Dr.

Dr. Hsu is a physician-scientist and Assistant Professor in the Department of Medicine at the University of California, San Diego. Her research explores the role of the gut microbiome and the gut-liver-brain axis in alcohol addiction and alcohol-associated liver disease through basic, translational, and clinical studies.

I am a paediatric Hepatologist and Gastroenterologist working in Bergamo, Italy. My current position is Director of Child Health and of the Paediatric Liver, GI and Transplantation Unit of the Hospital Papa Giovanni XXIII of Bergamo, and Associate Professor of Pediatrics at the University of Milano Bicocca, Milan. I trained as a Paediatrician at the University of Padua and as a Paediatric Hepatologist at King's College Hospital, London. I worked as Consultant Gastroenterologist and Hepatologist as well as Paediatric Intensivist, specializing in organ failure and transplantation.

My career goal as an independent physician-scientist investigator in the fields of biomedical engineering, stem cell biology, regenerative medicine, and virology is to build and translate ideas and discoveries in the laboratory to the clinic. My work has involved the development of new stem cell techniques and model systems with the goal to better understand human disease and to develop new clinical treatments. We have an established track record leveraging in vitro and in vivo platforms to model and study human liver disease.

I received my PhD degree in Cell and Molecular Biology from Paris-Est University in France in 2014. I accomplished my postdoctoral training at Mayo Clinic in 2020. Since then, I am an Assistant Professor at Mayo Clinic where I study the biology of hepatic stellate cells.

Michael Trauner, MD, received his medical education at the Karl-Franzens-University in Graz, Austria, where he also completed his clinical training in internal medicine and gastroenterology / hepatology. From 1994 to 1997 he postdoctoral research fellow at Yale University's Department of Internal Medicine and Liver Center in New Haven, USA. After returning to Graz, he established an internationally recognized research group in cholestatic and fatty liver diseases, and founded the Liver Center, serving as professor of experimental and clinical hepatology from 2005-2010.